Loading company…
Viron Therapeutics develops therapies for secretory disorders using its porosome platform.
Founded in 1997 and based in London, Canada, Viron Therapeutics develops therapies using its proprietary porosome platform. Its research targets secretory disorders associated with Alzheimer's disease, cystic fibrosis, and type 1 diabetes. In May 2006, it raised USD 20.00 mn in Series A funding led by Canadian Medical Discoveries Fund Inc., with participation from Amgen Ventures, BDC Capital, GrowthWorks Capital, Novartis International AG, and Trudell Medical International.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in